BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16909443)

  • 1. NF-kappaB modulators from Valeriana officinalis.
    Jacobo-Herrera NJ; Vartiainen N; Bremner P; Gibbons S; Koistinaho J; Heinrich M
    Phytother Res; 2006 Oct; 20(10):917-9. PubMed ID: 16909443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.
    Hattesohl M; Feistel B; Sievers H; Lehnfeld R; Hegger M; Winterhoff H
    Phytomedicine; 2008 Jan; 15(1-2):2-15. PubMed ID: 18160026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB inhibitory activity of compounds isolated from Cantharellus cibarius.
    Kim JA; Tay D; de Blanco EC
    Phytother Res; 2008 Aug; 22(8):1104-6. PubMed ID: 18570270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis by melampolides and repandolides.
    Ma G; Khan SI; Benavides G; Schühly W; Fischer NH; Khan IA; Pasco DS
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):35-43. PubMed ID: 17149609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation.
    Nam SM; Choi JH; Yoo DY; Kim W; Jung HY; Kim JW; Kang SY; Park J; Kim DW; Kim WJ; Yoon YS; Hwang IK
    Exp Gerontol; 2013 Nov; 48(11):1369-77. PubMed ID: 24055511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant effect and study of bioactive components of Valeriana sisymbriifolia and Nardostachys jatamansii in comparison to Valeriana officinalis.
    Dugaheh MA; Meisami F; Torabian Z; Sharififar F
    Pak J Pharm Sci; 2013 Jan; 26(1):53-8. PubMed ID: 23261727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
    Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
    Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators.
    Bremner P; Rivera D; Calzado MA; Obón C; Inocencio C; Beckwith C; Fiebich BL; Muñoz E; Heinrich M
    J Ethnopharmacol; 2009 Jul; 124(2):295-305. PubMed ID: 19397975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of nuclear factor kappaB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons.
    Cherng JM; Lin HJ; Hung MS; Lin YR; Chan MH; Lin JC
    Eur J Pharmacol; 2006 Oct; 547(1-3):10-21. PubMed ID: 16952351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-3 beta,4 beta-epoxyvalerenic acid from Valeriana officinalis.
    Dharmaratne HR; Nanayakkara NP; Khan IA
    Planta Med; 2002 Jul; 68(7):661-2. PubMed ID: 12143008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.
    Dietz BM; Mahady GB; Pauli GF; Farnsworth NR
    Brain Res Mol Brain Res; 2005 Aug; 138(2):191-7. PubMed ID: 15921820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous extract of Magnolia officinalis mediates proliferative capacity, p21WAF1 expression and TNF-alpha-induced NF-kappaB activity in human urinary bladder cancer 5637 cells; involvement of p38 MAP kinase.
    Lee SJ; Kim HM; Cho YH; Park K; Kim EJ; Jung KH; Kim CH; Kim WJ; Moon SK
    Oncol Rep; 2007 Sep; 18(3):729-36. PubMed ID: 17671727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for anti-inflammatory activity of 12 Arnica (Asteraceae) species assessed by inhibition of NF-kappaB and release of human neutrophil elastase.
    Ekenäs C; Zebrowska A; Schuler B; Vrede T; Andreasen K; Backlund A; Merfort I; Bohlin L
    Planta Med; 2008 Dec; 74(15):1789-94. PubMed ID: 18975264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A(1)- and GABA(A)-receptors.
    Sichardt K; Vissiennon Z; Koetter U; Brattström A; Nieber K
    Phytother Res; 2007 Oct; 21(10):932-7. PubMed ID: 17582590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB Activation by compounds found in Platycodon grandiflorum extract.
    Hong S; Yong Y; Kang K; Shin SY; Lee YH; Lim Y
    J Microbiol Biotechnol; 2009 Jun; 19(6):556-9. PubMed ID: 19597312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes.
    Boyadzhiev L; Kancheva D; Gourdon C; Metcheva D
    Pharmazie; 2004 Sep; 59(9):727-8. PubMed ID: 15497760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors.
    Lacher SK; Mayer R; Sichardt K; Nieber K; Müller CE
    Biochem Pharmacol; 2007 Jan; 73(2):248-58. PubMed ID: 17097622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice.
    Cuaz-Pérolin C; Billiet L; Baugé E; Copin C; Scott-Algara D; Genze F; Büchele B; Syrovets T; Simmet T; Rouis M
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):272-7. PubMed ID: 18032778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenolic constituents of Amorpha fruticosa that inhibit NF-kappaB activation and related gene expression.
    Dat NT; Lee JH; Lee K; Hong YS; Kim YH; Lee JJ
    J Nat Prod; 2008 Oct; 71(10):1696-700. PubMed ID: 18841906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappaB.
    Tanaka K; Hasegawa J; Asamitsu K; Okamoto T
    Eur J Pharmacol; 2007 Jun; 565(1-3):212-9. PubMed ID: 17346696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.